Nisa Investment Advisors
XENE icon

Nisa Investment Advisors’s Xenon Pharmaceuticals XENE Stock Holding History

Nisa Investment Advisors’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
1,830
+879
+92% +$48.8K ﹤0.01% 1497
2026
Q1 		$55.3K Buy
951
+27
+3% +$1.24K ﹤0.01% 1623
2025
Q4 		$41.4K Hold
924
– – ﹤0.01% 1678
2025
Q3 		$37.1K Buy
924
+235
+34% +$8.28K ﹤0.01% 1716
2025
Q2 		$21.6K Buy
+689
New +$22.5K ﹤0.01% 1901

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Nisa Investment Advisors's XENE Position: Q2 2026 in Review

Nisa Investment Advisors increased its Xenon Pharmaceuticals (XENE) stake by 92% in Q2 2026, buying an estimated $48.8K and bringing the position to 1,830 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Nisa Investment Advisors first reported a position in XENE in Q2 2025 and has held it in 5 quarters since. 127 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Nisa Investment Advisors held 1,830 shares of Xenon Pharmaceuticals worth $110K as of Q2 2026.
  • Nisa Investment Advisors bought 879 Xenon Pharmaceuticals shares in Q2 2026, an estimated $48.8K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1497 holding.
  • Nisa Investment Advisors first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 127 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.